fda not allowing compounded semaglutide Warns on Certain Forms of FDA Warns Against Using Compounded
Description
The liquid itself may still trigger TSA questioning if it exceeds 3.4 ounces, but the same medical exemption applies
:max_bytes(150000):strip_icc()/HEALTH-DWL-frame-final-4-83ab587c91ea4eab9e89a0e86add8e41.jpg)
Retatrutide Approval Timeline Phase 3 trials for Retatrutide are currently underway, with completion expected in late 2026

Medical Conditions People with insulin resistance, PCOS, or thyroid issues may lose weight differently

As with any newer medication, ongoing studies continue to evaluate long-term safety

Both medications stimulate the central nervous system and affect heart rate differently, creating potential for dangerous interactions
